Frontiers in Oncology | Cancer Genetics

Original Research

Published on 30 Jan 2023

Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndrome

in Cancer Genetics

Shujuan Pan
Hannah Cox
Jamie Willmott
Erin Mundt
Heidi Gorringe
Michelle Landon
Karla R. Bowles
Bradford Coffee
Benjamin B. Roa
Debora Mancini-DiNardo

Frontiers in Oncology

doi 10.3389/fonc.2023.1069467

3,850 views
3 citations

Review

Published on 30 Jan 2023

Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications

in Cancer Genetics

Juanjuan Luo
Ying Li
Tangxuan Zhang
Tianhan Xv
Chao Chen
Mengting Li
Qixiang Qiu
Yusheng Song
Shaogui Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.1092705

5,861 views
13 citations

Original Research

Published on 26 Jan 2023

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients

in Cancer Genetics

Hiu Ting Chan
Satoshi Nagayama
Masumi Otaki
Yoon Ming Chin
Yosuke Fukunaga
Masashi Ueno
Yusuke Nakamura
Siew-Kee Low

Frontiers in Oncology

doi 10.3389/fonc.2022.1055968

7,785 views
30 citations

Review

Published on 26 Jan 2023

CHD1, a multifaceted epigenetic remodeler in prostate cancer

in Cancer Genetics

Haoyan Li
Loraine Gigi
Di Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1123362

5,262 views
10 citations

Case Report

Published on 25 Jan 2023

Case Report: CTC1 mutations in a patient with diffuse hepatic and splenic hemangiomatosis complicated by Kasabach–Merritt syndrome

in Cancer Genetics

Xin He
Zi-Wen Guo
Xiao-Min Niu

Frontiers in Oncology

doi 10.3389/fonc.2023.1087790

1,418 views
2 citations

Original Research

Published on 24 Jan 2023

Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses

in Cancer Genetics

Qin Zhang
Lujie Yang
He Xiao
Zhaoqian Dang
Xunjie Kuang
Yanli Xiong
Jianwu Zhu
Zhou Huang
Mengxia Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1074955

3,182 views
4 citations

Review

Published on 23 Jan 2023

The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials

in Cancer Genetics

Yiqing Yang
Shiming Tan
Yaqian Han
Lisheng Huang
Ruiqian Yang
Zifan Hu
Yi Tao
Linda Oyang
Jinguan Lin
Qiu Peng

Frontiers in Oncology

doi 10.3389/fonc.2023.1100134

5,802 views
12 citations

Original Research

Published on 19 Jan 2023

A genome-wide association study of germline variation and melanoma prognosis

in Cancer Genetics

Vylyny Chat
Sasha Dagayev
Una Moran
Matija Snuderl
Jeffrey Weber
Robert Ferguson
Iman Osman
Tomas Kirchhoff

Frontiers in Oncology

doi 10.3389/fonc.2022.1050741

2,130 views
2 citations

Case Report

Published on 17 Jan 2023

Identification of KIT and BRAF mutations in thyroid tissue using next-generation sequencing in an Ecuadorian patient: A case report

in Cancer Genetics

Santiago Cadena-Ullauri
Elius Paz-Cruz
Rafael Tamayo-Trujillo
Patricia Guevara-Ramírez
Viviana Ruiz-Pozo
Paola Solis-Pazmino
Cristhian Garcia
Richard Godoy
Eddy Lincango-Naranjo
Ana Karina Zambrano

Frontiers in Oncology

doi 10.3389/fonc.2022.1101530

2,572 views
2 citations

Original Research

Published on 17 Jan 2023

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients

in Cancer Genetics

Bin Jia
Peiyi Xia
Junqiang Dong
Wenhao Feng
Wenjia Wang
Enjie Liu
Guozhong Jiang
Yanru Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.1086908

2,125 views
4 citations

Methods

Published on 17 Jan 2023

Landmark mediation survival analysis using longitudinal surrogate

in Cancer Genetics

Jie Zhou
Xun Jiang
H. Amy Xia
Brian P. Hobbs
Peng Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.999324

2,699 views
1 citation

Original Research

Published on 16 Jan 2023

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis

in Cancer Genetics

Yuxi Wu
Haofei Wang
Wei Xiang
Dongye Yi

Frontiers in Oncology

doi 10.3389/fonc.2022.1054012

2,620 views
3 citations

Editorial

Published on 16 Jan 2023

Editorial: Molecular genetics and therapeutic advances in renal carcinoma

in Cancer Genetics

David M. Nanus
James H. Finke
Saby George

Frontiers in Oncology

doi 10.3389/fonc.2022.1119373

955 views

Original Research

Published on 16 Jan 2023

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma

in Cancer Genetics

Peipei Xu
Sailiang Liu
Shu Song
Xiang yao
Xuechuan Li
Jie Zhang
Yinbing Liu
Ye Zheng
Ganglong Gao
Jingjing Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.965102

3,224 views
13 citations

Methods

Published on 16 Jan 2023

Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia

in Cancer Genetics

Anke Schilhabel
Monika Szczepanowski
Ellen J. van Gastel-Mol
Janina Schillalies
Jill Ray
Doris Kim
Michaela Nováková
Isabel Dombrink
Vincent H. J. van der Velden
Sebastian Boettcher

Frontiers in Oncology

doi 10.3389/fonc.2022.1111209

2,910 views
1 citation

Original Research

Published on 16 Jan 2023

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma

in Cancer Genetics

Yin Tian
Li’e Chen
Yun Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1057383

3,136 views
3 citations

Navigation group

Articles

Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndrome

Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients

CHD1, a multifaceted epigenetic remodeler in prostate cancer

Case Report: CTC1 mutations in a patient with diffuse hepatic and splenic hemangiomatosis complicated by Kasabach–Merritt syndrome

Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses

The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials

A genome-wide association study of germline variation and melanoma prognosis

Identification of KIT and BRAF mutations in thyroid tissue using next-generation sequencing in an Ecuadorian patient: A case report

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients

Landmark mediation survival analysis using longitudinal surrogate

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis

Editorial: Molecular genetics and therapeutic advances in renal carcinoma

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma

Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma